EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,432,624 | +35.0% | 217,668 | +66.5% | 0.01% | +22.2% |
| Q2 2023 | $2,541,799 | -48.7% | 130,751 | -25.1% | 0.01% | -50.0% |
| Q1 2023 | $4,955,104 | +150924.2% | 174,660 | +55.6% | 0.02% | +50.0% |
| Q4 2022 | $3,281 | -99.8% | 112,252 | +44.7% | 0.01% | +50.0% |
| Q3 2022 | $2,049,000 | -44.6% | 77,557 | -6.9% | 0.01% | -42.9% |
| Q2 2022 | $3,699,000 | -14.8% | 83,264 | -5.1% | 0.01% | +16.7% |
| Q1 2022 | $4,342,000 | +63.7% | 87,729 | +68.5% | 0.01% | +50.0% |
| Q4 2021 | $2,652,000 | +10.5% | 52,080 | +21.0% | 0.01% | 0.0% |
| Q3 2021 | $2,401,000 | – | 43,043 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |